Back
Orchestra BioMed Holdings Vs. Protalix BioTherapeutics Industry Stock Comparison
Sell
49
OBIO
Orchestra BioMed Holdings
Last Price:
5.33
Seasonality Move:
4.23%
Buy
79
PLX
Protalix BioTherapeutics
Last Price:
1.81
Seasonality Move:
86.79%
Sell
49
Orchestra BioMed Holdings (OBIO)
is a Sell
Is Orchestra BioMed Holdings a Buy, Sell or Hold?
- The current Orchestra BioMed Holdings [OBIO] share price is $5.35. The Score for OBIO is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- OBIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
79
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy, Sell or Hold?
- The current Protalix BioTherapeutics [PLX] share price is $1.80. The Score for PLX is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- PLX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
OBIO Stock Price Chart
What is Orchestra BioMed Holdings's stock price today?
-
The Orchestra BioMed Holdings share price today is $5.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OBIO is experiencing slight selling pressure.
PLX Stock Price Chart
What is Protalix BioTherapeutics's stock price today?
-
The Protalix BioTherapeutics share price today is $1.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing slight selling pressure.
OBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 46.84 | Sell |
| Chaikin Money Flow: | -24779 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.31 - 6.03) | Sell |
| Bollinger Bands (100): | (5.06 - 6.54) | Sell |
PLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 70.74 | Buy |
| Chaikin Money Flow: | -89307 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.35 - 1.77) | Buy |
| Bollinger Bands (100): | (0.93 - 1.43) | Buy |
OBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.39 | Sell |
| 20-day SMA: | 5.57 | Sell |
| 50-day SMA: | 5.54 | Sell |
| 200-day SMA: | 5.96 | Sell |
| 8-day EMA: | 5.42 | Sell |
| 20-day EMA: | 5.52 | Sell |
| 50-day EMA: | 5.61 | Sell |
| 200-day EMA: | 6.19 | Sell |
PLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.71 | Buy |
| 20-day SMA: | 1.64 | Buy |
| 50-day SMA: | 1.32 | Buy |
| 200-day SMA: | 1.2 | Buy |
| 8-day EMA: | 1.73 | Buy |
| 20-day EMA: | 1.62 | Buy |
| 50-day EMA: | 1.42 | Buy |
| 200-day EMA: | 1.29 | Buy |
Orchestra BioMed Holdings Earnings Growth & OBIO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.20 per share, and a decrease next year of $0.29 per share.
Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Orchestra BioMed Holdings Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Protalix BioTherapeutics Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||